1. Home
  2. DG vs BNTX Comparison

DG vs BNTX Comparison

Compare DG & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dollar General Corporation

DG

Dollar General Corporation

HOLD

Current Price

$124.57

Market Cap

27.5B

ML Signal

HOLD

Logo BioNTech SE

BNTX

BioNTech SE

HOLD

Current Price

$96.73

Market Cap

24.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DG
BNTX
Founded
1939
2008
Country
United States
Germany
Employees
194000
7807
Industry
Department/Specialty Retail Stores
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
27.5B
24.7B
IPO Year
2008
2019

Fundamental Metrics

Financial Performance
Metric
DG
BNTX
Price
$124.57
$96.73
Analyst Decision
Buy
Strong Buy
Analyst Count
21
13
Target Price
$139.60
$133.46
AVG Volume (30 Days)
2.1M
1.5M
Earning Date
06-02-2026
05-05-2026
Dividend Yield
2.07%
N/A
EPS Growth
34.05
N/A
EPS
4.49
N/A
Revenue
$42,724,369,000.00
N/A
Revenue This Year
$7.14
N/A
Revenue Next Year
$4.17
$3.37
P/E Ratio
$28.03
N/A
Revenue Growth
5.20
N/A
52 Week Low
$95.11
$79.81
52 Week High
$158.23
$124.00

Technical Indicators

Market Signals
Indicator
DG
BNTX
Relative Strength Index (RSI) 45.53 42.40
Support Level $115.31 $88.36
Resistance Level $126.20 $98.81
Average True Range (ATR) 4.03 3.37
MACD -0.21 -1.62
Stochastic Oscillator 15.21 0.55

Price Performance

Historical Comparison
DG
BNTX

About DG Dollar General Corporation

Since its beginning in 1939, Dollar General has grown to become the largest dollar store operator in the United States, with more than 20,000 small-box discount stores across 48 states. The firm generated over $42 billion in fiscal 2025 sales. The retailer maintains a heavy concentration of stores in rural and low-income markets underserved by big-box retailers. It's 11,000 stock-keeping units, including 2,000 priced at $1 or less, span consumables (82% of sales), seasonal items (10%), home products (5%), and apparel (3%). More than 20% of sales are derived from private label.

About BNTX BioNTech SE

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens and neoantigens; monospecific and bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.

Share on Social Networks: